LabCompass

Erin Macrae

Medicine · The Ohio State University

OpenAlex
Mid career · publishing since 2001
HER2/EGFR in Cancer ResearchAdvanced Breast Cancer TherapiesBreast Cancer Treatment StudiesCancer Treatment and PharmacologyCancer Cells and Metastasis

Publications

40

Citations

1,685

Est. group size

~3

Recurring co-author estimate

Active years

24

Publishing since 2001

Research summary
AI-generated

Erin Macrae's work focuses on clinical trials and treatment guidelines for breast cancer, particularly hormone receptor-positive and HER2-related subtypes, as well as studies of targeted drug combinations (such as dabrafenib and trametinib) for tumors with specific genetic mutations (BRAF V600E/K). This research contributes to clinical oncology practice guidelines and evaluates new drug combinations in advanced cancer patients.

Breast cancer treatmentHER2-targeted therapyHormone receptor-positive metastatic cancerBRAF-mutation targeted therapyClinical trial guideline development

Publication output has been variable over the last decade, with a peak in 2020, a gap in 2023, and a recent uptick in 2024, though the 5-year average remains low at about 1.2 papers per year.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.2/year recently
2017: 2 publications17182019: 3 publications192020: 7 publications7202021: 1 publication212022: 1 publication22232024: 5 publications242526
Recent publications
Publishes in
  • Journal of Clinical Oncology×5
  • Cancer Research×3
  • BMC Cancer×2
  • JCO Precision Oncology×2
  • medRxiv×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile